Phase I study of ABT-199 (GDC-0199) in patients with relapsed/refractory non-Hodgkin lymphoma: responses observed in diffuse large B-cell (DLBCL) and follicular lymphoma (FL) at higher cohort doses.
暂无分享，去创建一个
A. Roberts | M. Davids | J. Pagel | W. Wierda | J. Gerecitano | S. Enschede | R. Humerickhouse | J. Seymour | M. Dunbar | M. Anderson | B. Kahl | Ming Zhu | E. Cerri | N. Montalvo | Jianning Yang | Lori A. Gressick | Nikita Rudersdorf